Osurnia

RSS

terbinafine / florfenicol / betamethasone

Authorised
This medicine is authorised for use in the European Union.
Veterinary health alerts

Overview

This is a summary of the European Public Assessment Report. Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 11/07/2019

Authorisation details

Product details
Name
Osurnia
Agency product number
EMEA/V/C/003753
Active substance
  • terbinafine / florfenicol
  • betamethasone acetate
International non-proprietary name (INN) or common name
terbinafine / florfenicol / betamethasone
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QS02CA90
Publication details
Marketing-authorisation holder
Elanco GmbH
Revision
7
Date of issue of marketing authorisation valid throughout the European Union
31/07/2014
Contact address

Heinz-Lohmann-Str 4
27472 Cuxhaven
Germany

Product information

03/07/2019 Osurnia - EMEA/V/C/003753 - R/0014

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Otologicals corticosteroids and antiinfectives in combination

Therapeutic indication

Treatment of acute otitis externa

Assessment history

How useful was this page?

Add your rating